Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5175074
Max Phase: Preclinical
Molecular Formula: C34H54N12O10S2
Molecular Weight: 855.01
Associated Items:
ID: ALA5175074
Max Phase: Preclinical
Molecular Formula: C34H54N12O10S2
Molecular Weight: 855.01
Associated Items:
Canonical SMILES: CC(C)[C@@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CN)CSCc2cccc(n2)CSC[C@@H](C(=O)O)NC1=O
Standard InChI: InChI=1S/C34H54N12O10S2/c1-17(2)27-32(54)45-24(33(55)56)16-58-14-19-6-3-5-18(40-19)13-57-15-23(41-26(49)11-35)31(53)44-22(12-47)30(52)42-20(7-4-10-39-34(37)38)28(50)43-21(29(51)46-27)8-9-25(36)48/h3,5-6,17,20-24,27,47H,4,7-16,35H2,1-2H3,(H2,36,48)(H,41,49)(H,42,52)(H,43,50)(H,44,53)(H,45,54)(H,46,51)(H,55,56)(H4,37,38,39)/t20-,21-,22-,23-,24-,27-/m0/s1
Standard InChI Key: UKWWKZPGXBTTQB-IPTDFQASSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 855.01 | Molecular Weight (Monoisotopic): 854.3527 | AlogP: -4.31 | #Rotatable Bonds: 12 |
Polar Surface Area: 376.03 | Molecular Species: ZWITTERION | HBA: 14 | HBD: 13 |
#RO5 Violations: 3 | HBA (Lipinski): 22 | HBD (Lipinski): 16 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.64 | CX Basic pKa: 11.50 | CX LogP: -7.59 | CX LogD: -8.14 |
Aromatic Rings: 1 | Heavy Atoms: 58 | QED Weighted: 0.05 | Np Likeness Score: 0.69 |
1. Gonschorek P, Zorzi A, Maric T, Le Jeune M, Schüttel M, Montagnon M, Gómez-Ojea R, Vollmar DP, Whitfield C, Reymond L, Carle V, Verma H, Schilling O, Hovnanian A, Heinis C.. (2022) Phage Display Selected Cyclic Peptide Inhibitors of Kallikrein-Related Peptidases 5 and 7 and Their In Vivo Delivery to the Skin., 65 (14.0): [PMID:35653695] [10.1021/acs.jmedchem.2c00306] |
Source(1):